Table 4.
Pharmacological treatments for underlying cardiometabolic and psychological comorbidities in men with ED and men without ED.
| Medications | ED status | Two-sided p value | |
|---|---|---|---|
| ED (n = 5,185) | No ED (n = 7,305) | ||
| Alpha blocker-heart conditions, n (%) | 300 (5.8) | 108 (1.5) | <0.001 |
| Antidepressants, n (%) | 891 (17.2) | 719 (9.8) | <0.001 |
| Blood pressure medication, n (%) | 1,677 (32.3) | 1,034 (14.2) | <0.001 |
| Statins, n (%) | 1,479 (28.5) | 845 (11.6) | <0.001 |
| Diabetes medication, n (%) | 712 (13.7) | 355 (4.9) | <0.001 |
| Nitrates, n (%) | 170 (3.3) | 46 (0.6) | <0.001 |
| Vasodilators, n (%) | 114 (2.2) | 28 (0.4) | <0.001 |
| ≥1 of the above, n (%) | 2,836 (54.7) | 2,047 (28.0) | <0.001 |
ED, erectile dysfunction.